Skip to main content
NCBI home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1997 Nov;4(6):748–752. doi: 10.1128/cdli.4.6.748-752.1997

Afipia clevelandensis antibodies and cross-reactivity with Brucella spp. and Yersinia enterocolitica O:9.

M Drancourt 1, P Brouqui 1, D Raoult 1
PMCID: PMC170653  PMID: 9384302

Abstract

Afipia clevelandensis is a recently described gram-negative bacterium whose potential pathogenic role in human disease is under investigation. Only one strain, from the pretibial lesion of a patient hospitalized with necrotizing pancreatitis for 5 months, has been isolated. Using an indirect immunofluorescence assay to detect anti-A. clevelandensis antibodies, we found a seroprevalence of 1.5% among 30,194 sera routinely submitted for laboratory diagnosis of rickettsial diseases. However, among the 52 patients who were clinically evaluable and who exhibited detectable antibodies against A. clevelandensis, 42% were eventually diagnosed as certainly or probably having brucellosis and 15% were eventually diagnosed as certainly or probably having Yersinia enterocolitica O:9 infection, which is the serotype most often encountered in Europe. Western immunoblotting and cross-adsorption tests showed that an 11.5-kDa proteinase K-labile band and a 21-kDa proteinase-stable band, presumably lipopolysaccharide, were responsible for cross-reactivity among A. clevelandensis, Brucella abortus, and Y. enterocolitica O:9. Other diagnoses included nosocomial infections and various community-acquired diseases for which the role of A. clevelandensis remains undefined. Physicians and clinical microbiologists should be aware of this cross-reactivity in future assessments of the role of A. clevelandensis in human pathology.

Full Text

The Full Text of this article is available as a PDF (640.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahvonen P., Jansson E., Aho K. Marked cross-agglutination between Brucellae and a subtype of Yersinia enterocolitica. Acta Pathol Microbiol Scand. 1969;75(2):291–295. [PubMed] [Google Scholar]
  2. Alkan S., Morgan M. B., Sandin R. L., Moscinski L. C., Ross C. W. Dual role for Afipia felis and Rochalimaea henselae in cat-scratch disease. Lancet. 1995 Feb 11;345(8946):385–385. doi: 10.1016/s0140-6736(95)90370-4. [DOI] [PubMed] [Google Scholar]
  3. Anderson B., Kelly C., Threlkel R., Edwards K. Detection of Rochalimaea henselae in cat-scratch disease skin test antigens. J Infect Dis. 1993 Oct;168(4):1034–1036. doi: 10.1093/infdis/168.4.1034. [DOI] [PubMed] [Google Scholar]
  4. Anderson B., Sims K., Regnery R., Robinson L., Schmidt M. J., Goral S., Hager C., Edwards K. Detection of Rochalimaea henselae DNA in specimens from cat scratch disease patients by PCR. J Clin Microbiol. 1994 Apr;32(4):942–948. doi: 10.1128/jcm.32.4.942-948.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bergmans A. M., Groothedde J. W., Schellekens J. F., van Embden J. D., Ossewaarde J. M., Schouls L. M. Etiology of cat scratch disease: comparison of polymerase chain reaction detection of Bartonella (formerly Rochalimaea) and Afipia felis DNA with serology and skin tests. J Infect Dis. 1995 Apr;171(4):916–923. doi: 10.1093/infdis/171.4.916. [DOI] [PubMed] [Google Scholar]
  6. Birkness K. A., George V. G., White E. H., Stephens D. S., Quinn F. D. Intracellular growth of Afipia felis, a putative etiologic agent of cat scratch disease. Infect Immun. 1992 Jun;60(6):2281–2287. doi: 10.1128/iai.60.6.2281-2287.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Brenner D. J., Hollis D. G., Moss C. W., English C. K., Hall G. S., Vincent J., Radosevic J., Birkness K. A., Bibb W. F., Quinn F. D. Proposal of Afipia gen. nov., with Afipia felis sp. nov. (formerly the cat scratch disease bacillus), Afipia clevelandensis sp. nov. (formerly the Cleveland Clinic Foundation strain), Afipia broomeae sp. nov., and three unnamed genospecies. J Clin Microbiol. 1991 Nov;29(11):2450–2460. doi: 10.1128/jcm.29.11.2450-2460.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bundle D. R., Gidney M. A., Perry M. B., Duncan J. R., Cherwonogrodzky J. W. Serological confirmation of Brucella abortus and Yersinia enterocolitica O:9 O-antigens by monoclonal antibodies. Infect Immun. 1984 Nov;46(2):389–393. doi: 10.1128/iai.46.2.389-393.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Caroff M., Bundle D. R., Perry M. B., Cherwonogrodzky J. W., Duncan J. R. Antigenic S-type lipopolysaccharide of Brucella abortus 1119-3. Infect Immun. 1984 Nov;46(2):384–388. doi: 10.1128/iai.46.2.384-388.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Caroff M., Bundle D. R., Perry M. B. Structure of the O-chain of the phenol-phase soluble cellular lipopolysaccharide of Yersinia enterocolitica serotype O:9. Eur J Biochem. 1984 Feb 15;139(1):195–200. doi: 10.1111/j.1432-1033.1984.tb07994.x. [DOI] [PubMed] [Google Scholar]
  11. Chart H., Okubadejo O. A., Rowe B. The serological relationship between Escherichia coli O157 and Yersinia enterocolitica O9 using sera from patients with brucellosis. Epidemiol Infect. 1992 Feb;108(1):77–85. doi: 10.1017/s0950268800049529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Díaz-Aparicio E., Aragón V., Marín C., Alonso B., Font M., Moreno E., Pérez-Ortiz S., Blasco J. M., Díaz R., Moriyón I. Comparative analysis of Brucella serotype A and M and Yersinia enterocolitica O:9 polysaccharides for serological diagnosis of brucellosis in cattle, sheep, and goats. J Clin Microbiol. 1993 Dec;31(12):3136–3141. doi: 10.1128/jcm.31.12.3136-3141.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. English C. K., Wear D. J., Margileth A. M., Lissner C. R., Walsh G. P. Cat-scratch disease. Isolation and culture of the bacterial agent. JAMA. 1988 Mar 4;259(9):1347–1352. doi: 10.1001/jama.259.9.1347. [DOI] [PubMed] [Google Scholar]
  14. Hall G. S., Pratt-Rippin K., Washington J. A. Isolation of agent associated with cat scratch disease bacillus from pretibial biopsy. Diagn Microbiol Infect Dis. 1991 Nov-Dec;14(6):511–513. doi: 10.1016/0732-8893(91)90009-5. [DOI] [PubMed] [Google Scholar]
  15. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  16. Moss C. W., Holzer G., Wallace P. L., Hollis D. G. Cellular fatty acid compositions of an unidentified organism and a bacterium associated with cat scratch disease. J Clin Microbiol. 1990 May;28(5):1071–1074. doi: 10.1128/jcm.28.5.1071-1074.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Müller H. E. Detection of antibodies to Afipia species by the microagglutination test. Eur J Clin Microbiol Infect Dis. 1993 Dec;12(12):951–954. doi: 10.1007/BF01992172. [DOI] [PubMed] [Google Scholar]
  18. O'Connor S. P., Dorsch M., Steigerwalt A. G., Brenner D. J., Stackebrandt E. 16S rRNA sequences of Bartonella bacilliformis and cat scratch disease bacillus reveal phylogenetic relationships with the alpha-2 subgroup of the class Proteobacteria. J Clin Microbiol. 1991 Oct;29(10):2144–2150. doi: 10.1128/jcm.29.10.2144-2150.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Regnery R. L., Olson J. G., Perkins B. A., Bibb W. Serological response to "Rochalimaea henselae" antigen in suspected cat-scratch disease. Lancet. 1992 Jun 13;339(8807):1443–1445. doi: 10.1016/0140-6736(92)92032-b. [DOI] [PubMed] [Google Scholar]
  20. Velasco J., Díaz R., Grilló M. J., Barberán M., Marín C., Blasco J. M., Moriyón I. Antibody and delayed-type hypersensitivity responses to Ochrobactrum anthropi cytosolic and outer membrane antigens in infections by smooth and rough Brucella spp. Clin Diagn Lab Immunol. 1997 May;4(3):279–284. doi: 10.1128/cdli.4.3.279-284.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES